SUVEN vs SYNGENE: Stock Comparison
SYNGENE INTERNATIONAL is the larger company by market capitalisation. SUVEN LIFE SCIENCES shows a lower P/E and faster revenue growth, while SYNGENE INTERNATIONAL shows a higher ROE, a higher dividend yield and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
SUVEN leads 3; SYNGENE leads 9 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | SUVEN | SYNGENE |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Research Analytics & Technology | Healthcare Research Analytics & Technology |
Price
| Metric | SUVEN | SYNGENE |
|---|---|---|
| Live Price | ₹269.4 | ₹451.7 |
| Day Change | -2.71% | 3.28% |
| Volume | 3.34 L | 25.58 L |
| 52-Week High | ₹403.35 | ₹678.95 |
| 52-Week Low | ₹124.11 | ₹344.45 |
| Distance from 52W High | -33.21% | -33.47% |
Valuation
| Metric | SUVEN | SYNGENE |
|---|---|---|
| Market Cap | ₹7,609 Cr | ₹18,268 Cr |
| P/E Ratio | 0x | 97.95x |
| P/B Ratio | 15.66x | 3.75x |
| EPS | ₹-3.78 | ₹0.8 |
| Book Value | ₹20.93 | ₹119.88 |
| Dividend Yield | 0% | 0.28% |
Growth
| Metric | SUVEN | SYNGENE |
|---|---|---|
| Revenue Growth (TTM YoY) | 3.6% | 1.8% |
| EPS Growth (TTM YoY) | 0% | -19.5% |
| Qtr Sales Growth | -66.39% | 13.14% |
| Qtr Profit Growth | 16.2% | 457.78% |
Profitability & Leverage
| Metric | SUVEN | SYNGENE |
|---|---|---|
| ROE | -3.65% | 6.48% |
| ROCE | -3.64% | 6.92% |
| Net Margin | -3,884.13% | 11.26% |
| Operating Margin | -768.9% | 12.3% |
| Debt to Equity | 0x | 0x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | SUVEN | SYNGENE |
|---|---|---|
| Promoter Holding | 65.47% | 52.59% |
| FII Holding | 0.46%▼ 0.02 pp | 10.14%▼ 1.68 pp |
| DII Holding | 2.17%▼ 0.56 pp | 29.3%▲ 1.28 pp |
| Public Holding | 31.9%▲ 0.58 pp | 7.56%▲ 0.42 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SUVEN LIFE SCIENCES and SYNGENE INTERNATIONAL.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.

